News Sentiment

GRDN sentiment intelligence

Guardian Pharmacy Services, Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 60 Balanced news tone 54 relevant articles
Exchange NYSE United States
Sector Healthcare Market context
Industry Medical Care Facilities Read-through group
Latest close 40.96 Week of 10 Jul 2026
Weighted tone 60/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

82/100 classification confidence.

Company focus 54

directly relevant articles

Source quality 3

high-authority source matches

Trend context Trend active

-2.5% over one week, -4.9% over four weeks, trend active, and materially above fair value.

Latest direct headline Neutral

Guardian Pharmacy to report Q2 2026 results on August 6

Market Reaction

Balanced read

71/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 82/100 classification
One-week reaction -2.5% Price reacting lower
Trend fit Trend active -4.9% over four weeks
Fair value 52.4% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 22
Neutral 32
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 54
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Market source 8
TradingView 7
Moomoo 4
Quartr 3
MT Newswires 3
simplywall.st 3
Stock Titan 3
Simply Wall Street 2

Event Lens

What the news is about

Classified themes
Market update 34
Earnings 10
Deals and strategy 6
Analyst action 2
Capital return 1
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-54 of 54
The Globe and Mail Direct company coverage

Truist Financial Sticks to Their Buy Rating for Guardian Pharmacy Services, Inc. Class A (GRDN)

Truist Financial has reiterated its Buy rating for Guardian Pharmacy Services, Inc. Class A (GRDN), setting a price target of $47.00. This recommendation is supported by analyst Richard Newitter, who has a history of successful stock picks in the Healthcare sector. The company re

Tone
Positive 74/100
Event
Analyst action
Published
24 Jun 2026 23:40
Source
The Globe and Mail
Investing.com South Africa Direct company coverage

Form 8K Guardian Pharmacy Services Inc For: 22 June By Investing.com

Investing.com reports that Guardian Pharmacy Services Inc. filed a Form 8K on June 22. The article provides the company's stock symbol (GRDN) and its current performance (up 8.69%). It also features real-time financial data for various global indices, commodities, and currencies.

Tone
Neutral 50/100
Event
Market update
Published
22 Jun 2026 22:42
Source
Investing.com South Africa